Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08DSC
|
|||
| Former ID |
DIB011345
|
|||
| Drug Name |
BST-1005
|
|||
| Synonyms |
BST-1004; Anti-laminin gamma2 mAbs (cancer), BioStratum; Anti-laminin gamma2 monoclonal antibodies (cancer), BioStratum
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Preclinical | [1] | |
| Company |
BioStratum Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019225) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019225) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.